 multicent trial oral zidovudin children advanc human immunodefici viru diseas protocol studi group background and method zidovudin effect antiretrovir treatment adult human immunodefici viru hiv infect safeti zidovudin toler therapeut respons drug children advanc hiv diseas outpati trial zidovudin mg squar meter body-surfac area dose mouth hour serial measur clinic immunolog virolog index children week treatment zidovudin result children mean age year rang month year initi trial zidovudin week median follow-up week patient zidovudin episod hematolog toxic children percent anemia hemoglobin level liter children percent neutrophil count liter percent mani abnorm children transfus modif dose zidovudin children drug hematolog toxic kaplan-mei analysi probabl surviv week week improv weight gain cognit function children year old serum cerebrospin fluid concentr antigen proport cerebrospin fluid cultur neg hiv lymphocyt count mean base line liter first week improv week conclus zidovudin dose mg squar meter hour children advanc hiv diseas result clinic immunolog virolog improv children similar zidovudin adult